Blueprint Genetics

company

About

Blueprint Genetics is a healthcare firm based in Helsinki, San Francisco and Dubai, providing clinical genetic testing to patients.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Hospital
Founded date
Apr 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).

The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinical insight to the results statements.

The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.

The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.

The company is based in Helsinki, Finland and has an office also in Los Angeles, CA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.90M
Blueprint Genetics has raised a total of $3.90M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 7, 2020 Debt Financing 1 Detail
Sep 1, 2014 Series Unknown $3.90M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Blueprint Genetics is funded by 2 investors. Bootstrap Europe and Tekes Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Bootstrap Europe Debt Financing
Tekes Venture Capital Series Unknown